Searched for: subject:"Multiple%5C+Myeloma"
(1 - 12 of 12)
document
Asosingh, K. (author), Radl, J. (author), van Riet, I. (author), van Camp, B. (author), van der Kerken, K. (author), TNO Preventie en Gezondheid (author)
Chemicals/CAS: Cancer Vaccines; Myeloma Proteins; pristane, 1921-70-6; Terpenes; Vaccines, DNA
article 2000
document
Teronen, O. (author), Laitinen, M. (author), Salo, T. (author), Hanemaaijer, R. (author), Heikkilä, P. (author), Konttinen, Y.T. (author), Sorsa, T. (author), TNO Preventie en Gezondheid (author)
article 2000
document
Zhu, D. (author), van Arkel, C. (author), King, C.A. (author), van Meirvenne, S. (author), de Greef, C. (author), Thielemans, K. (author), Radl, J. (author), Stevenson, F.K. (author), TNO Preventie en Gezondheid (author)
The 5T series of multiple myelomas (MM) and Waldenstrsom's macroglobulinaemia-like lymphomas (WM), which developed spontaneously in ageing mice of the C57BL/KaLwRij strain, shows clinical and biological features that closely resemble their corresponding human diseases. In order to compare the patterns of somatic mutation in V(H) genes of mouse...
article 1998
document
Garrett, I.R. (author), Dallas, S. (author), Radl, J. (author), Mundy, G.R. (author), TNO Preventie en Gezondheid (author)
Myeloma causes a devastating and unique form of osteolytic bone disease. Although osteoclast activation is responsible for bone destruction, the precise mechanisms by which myeloma cells increase osteoclast activity have not been defined. An animal model of human myeloma bone disease mould help in clarification of these mechanisms. Multiple...
article 1997
document
van der Kerken, K. (author), de Raeve, H. (author), Goes, E. (author), van Meirvenne, S. (author), Radl, J. (author), van Riet, I. (author), Thielemans, K. (author), van Camp, B. (author), TNO Preventie en Gezondheid (author)
The aim of this study was to evaluate the tissue infiltration and phenotypic adhesion profile of 5T2 multiple myeloma (MM) and 5T33 MM cells and to correlate it with that observed in human disease. For each line, 30 mice were intravenously inoculated with myeloma cells and at a clear-cut demonstrable serum paraprotein concentration; mice were...
article 1997
document
van den Akker, Th.W. (author), Radl, J. (author), Franken-Postma, E. (author), Hagemeijer, A. (author), Gaubius Instituut TNO (author)
Multiple myeloma (MM) and Waldenström's macroglobulinemia-like lymphoma (MW) appear spontaneously in C57BL/KaLwRij mice at a frequency of 0.5% and 0.2%, respectively. They can readily be propagated by intravenous transfer of mainly bone marrow or spleen cells into syngeneic recipients. Previous studies demonstrated that these mouse malignant...
article 1996
document
Radl, J. (author), van Arkel, C. (author), Hopstaken, C.M. (author), Hogenesch, H. (author), TNO Preventie en Gezondheid (author)
Persons undergoing maintenance immunosuppressive treatment (MIST) were shown to be at increased risk for the development of early malignancies, often of cells of the immune system. Very little is known about the late effects of MIST. Some clinical studies indicated an age-related increase in the incidence of plasma-cell disorders, in particular...
article 1996
document
Vanderkerken, K. (author), Goes, E. (author), de Raeve, H. (author), Radl, J. (author), van Camp, B. (author), TNO Preventie en Gezondheid (author)
The evolution of bone lesions in transplantable C57BL/KaLwRij 5T mouse myeloma (MM) has been followed in vivo. Mice were anaesthetised and a radiograph of the pelvis and hind legs was performed by a radiograph dedicated for mammography. This is the first description of an in vivo technique under experimental conditions whereby the development of...
article 1996
document
Radl, J. (author), Instituut voor Verouderings- en Vaatziekten Onderzoek TNO (author)
article 1992
document
Radl, J. (author), Punt, Y.A. (author), van den Enden-Vieveen, M.H.M. (author), Bentvelzen, P.A.J. (author), Bakkus, M.H.C. (author), van den Akker, T.W. (author), Benner, R. (author), Instituut voor Experimentele Gerontologie TNO (author)
Consistent chromosomal translocations involving the c-myc cellular oncogene and one of the three immunoglobulin loci are typical for human Burkitt's lymphoma, induced mouse plasmacytoma (MPC) and spontaneously arising rat immunocytoma (RIC). Another plasma cell malignancy, multiple myeloma (MM), arising spontaneously in the ageing C57BL/KaLwRij...
article 1990
document
Radl, J. (author), Croese, J.W. (author), Zurcher, C. (author), van den Enden-Vieveen, M.H.M. (author), de Leeuw, A.M. (author), Instituut voor Experimentele Gerontologie TNO (author)
Animal models of spontaneous and induced plasmacytomas in some inbred strains of mice have proven to be useful tools for different studies on tumorigenesis and immunoregulation. Their wide applicability and the fact that after their intravenous transplantation, the recipient mice developed bone lesions, led in some instances to an incorrect use...
article 1988
document
Croese, J.W. (author), Vas Nunes, C.M. (author), Radl, J. (author), Enden-Vieveen, M.H.M. (author), van den Brondijk, R.J. (author), Boersma, W.J.A. (author), Instituut voor Experimentele Gerontologie TNO (author)
The transplantable C57BL/KaLwRij mouse 5T2 multiple myeloma (MM) is a new animal model for studies on MM in man. Histological examination of the 5T2 MM cells revealed their morphological heterogeneity. In this study we investigated whether this heterogeneity reflects subpopulations of 5T2 MM cells with different biological properties. 5T2 MM...
article 1987
Searched for: subject:"Multiple%5C+Myeloma"
(1 - 12 of 12)